Novartis tests new shot for high blood pressure
NCT ID NCT06905327
Summary
This was an early safety study to test a new injectable drug called QCZ484. It involved 56 healthy volunteers and people with mild high blood pressure to see how their bodies handled a single dose. The main goal was to check for side effects and measure how the drug moved through the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Novartis Investigative Site
Herston, Queensland, 4006, Australia
-
Novartis Investigative Site
Morayfield, Queensland, 4506, Australia
-
Novartis Investigative Site
Adelaide, 5000, Australia
-
Novartis Investigative Site
Auckland, 0622, New Zealand
Conditions
Explore the condition pages connected to this study.